Back to top
more

Alcon (ALC)

(Delayed Data from NYSE)

$78.77 USD

78.77
1,115,931

-0.07 (-0.09%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $78.79 +0.02 (0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (94 out of 252)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Alcon (ALC) to Report Q1 Earnings: What's in the Cards?

Strength in Vision Care with the addition of new products and recent acquisition is likely to have contributed to Alcon's (ALC) first-quarter performance.

Trina Mukherjee headshot

3 Medical Product Stocks Set to Beat on Earnings This Season

Medical product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how CGC, HAE and ALC are poised ahead of their earnings releases.

What's in the Offing for Synaptics (SYNA) This Earnings Season?

Synaptics' (SYNA) third-quarter fiscal 2022 performance is likely to have benefited from increased bookings and new Organic Light Emitting Diode touch-sensor design wins.

EPAM Systems (EPAM) to Report Q1 Earnings: What's in Store?

Though the accelerated digital modernization across industries is likely to aid EPAM Systems' (EPAM) Q1 results, the discontinuation of Russian operations is likely to have hurt the top and bottom lines.

Ball Corp (BLL) to Report Q1 Earnings: What's in the Offing?

Ball Corp's (BLL) Q1 performance is likely to reflect benefits from solid demand for beverage can packaging, can plant capacity expansions and robust aerospace backlog.

fuboTV (FUBO) to Report Q1 Earnings: What's in the Cards?

fuboTV's (FUBO) first-quarter results are expected to reflect growth in paid subscribers and viewing supported by increased advertiser demand on the company's sports-first live TV streaming platform.

Block (SQ) to Report Q1 Earnings: What's in the Offing?

Block's (SQ) first-quarter results are expected to reflect strength across its seller base and omnichannel offerings amid rising expenses and the pandemic-led uncertainties.

eBay (EBAY) to Report Q1 Earnings: What's in the Offing?

eBay's (EBAY) first-quarter 2022 results are likely to reflect the impacts of strong momentum across Promoted Listings and Managed payments.

Molina Healthcare (MOH) Q1 Earnings Beat on Higher Premiums

Molina Healthcare (MOH) boosts premium and bottom-line guidance for 2022, reflecting improving business.

Humana (HUM) Q1 Earnings Beat on Solid Healthcare Services

Humana (HUM) still has $2 billion remaining under its share repurchase authorization.

Exact Sciences (EXAS) Q1 Earnings Top Estimates, Sales View Up

Robust performances by the Screening and Precision Oncology segments drove Exact Sciences' (EXAS) first-quarter top line.

Charles River (CRL) to Report Q1 Earnings: What's in Store?

Robust global demand for the research model and multiple initiatives to expedite the discovery process are likely to have contributed to Charles River's (CRL) first-quarter results.

Edwards Lifesciences (EW) Q1 Earnings Top Estimates, Margins Up

Increased adoption of the PASCAL platform along with continued strength in the HemoSphere monitoring platform drove Edwards Lifesciences' (EW) Q1 revenues.

IDEXX (IDXX) to Report Q1 Earnings: What's in the Cards?

Strength in CAG Diagnostics and Water businesses is likely to have contributed to IDEXX's (IDXX) top line in the first quarter.

Henry Schein (HSIC) to Report Q1 Earnings: What's in Store?

Robust demand in the global dental market with the steady improvement in patient traffic is likely to have contributed to Henry Schein's (HSIC) Q1 performance.

CVS Health (CVS) to Report Q1 Earnings: What's in the Cards?

Increased digital health adoption and growing pharmacy sales are likely to have contributed to CVS Health's (CVS) Q1 performance.

The Zacks Analyst Blog Highlights Alcon, Zimmer Biomet, Cardiovascular Systems, Abbott and Intuitive Surgical

Alcon, Zimmer Biomet, Cardiovascular Systems, Abbott and Intuitive Surgical have been included in this Analyst Blog.

Fulgent Genetics (FLGT) to Post Q1 Earnings: What's in Store?

Strategic investments and expanding operations in China are likely to have contributed to Fulgent Genetics' (FLGT) first-quarter performance.

Urmimala Biswas headshot

3 Medical Product Stocks Poised to Beat This Earnings Season

Medical product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how ALC, ZBH and CSII are poised ahead of their earnings releases.

LabCorp (LH) to Report Q1 Earnings: What's in the Cards?

Robust base business growth and notable launches are likely to have contributed to LabCorp's (LH) Q1 performance.

Align Technology (ALGN) to Post Q1 Earnings: What's in Store?

Robust demand for iTero scanners and increasing Invisalign case submissions are expected to have contributed to Align Technology's (ALGN) Q1 performance.

Zacks Industry Outlook Highlights Alcon, STERIS and Abiomed

Alcon, STERIS and Abiomed have been highlighted in this Industry Outlook article.

Urmimala Biswas headshot

3 Medical Instruments Stocks to Buy Despite Industry Headwinds

The Zacks Medical - Instruments industry is growing on R&D investments. ALC, STE and ABMD are set to gain the most. Yet, demand for non-COVID businesses is on the decline with the new COVID variant disrupting the trend.

Alcon (ALC) Stock Rallies 4.7% Since Posting Q4 Earnings Beat

Alcon (ALC) stock rallies on robust growth across all Surgical and Vision Care sales categories.

Alcon's (ALC) Surgical Arm Rebounds, New Launches Aid Growth

In Vision Care, Alcon (ALC) continues to see strong demand for PRECISION1 and PRECISION1 for Astigmatism, which are the company's newest contact lenses for the mainstream market.